ID

35104

Beschreibung

LIquid BIopsies in Lung Cancer (LIBIL); ODM derived from: https://clinicaltrials.gov/show/NCT02511288

Link

https://clinicaltrials.gov/show/NCT02511288

Stichworte

Versionen (1)
  1. 17.02.19 17.02.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

17. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

Englisch

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 Formulare  
Criteria
Beschreibung

Criteria

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
Beschreibung

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C0332291
UMLS CUI [2,2]
C0026882
UMLS CUI [2,3]
C0449438
inclusion at the time of diagnostic or at relapse
Beschreibung

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Beschreibung

Neoplasm Biopsy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Beschreibung

Therapeutic procedure Before Liquid Biopsy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
cohort 2 inclusion criteria
Beschreibung

Cohort Number | Inclusion criteria

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0599755
UMLS CUI [1,2]
C0237753
UMLS CUI [2]
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
Beschreibung

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C1704257
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C3266992
UMLS CUI [4]
C1511021
UMLS CUI [5]
C3273087
UMLS CUI [6]
C4329227
UMLS CUI [7]
C4331215
UMLS CUI [8]
C1711106
inclusion at the time of diagnostic or at relapse
Beschreibung

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Beschreibung

Neoplasm Biopsy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Beschreibung

Therapeutic procedure Before Liquid Biopsy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0332291 (UMLS CUI [2,1])
C0026882 (UMLS CUI [2,2])
C0449438 (UMLS CUI [2,3])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Cohort Number | Inclusion criteria
Item
cohort 2 inclusion criteria
boolean
C0599755 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1512693 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C1704257 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C3266992 (UMLS CUI [3])
C1511021 (UMLS CUI [4])
C3273087 (UMLS CUI [5])
C4329227 (UMLS CUI [6])
C4331215 (UMLS CUI [7])
C1711106 (UMLS CUI [8])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video